Maini Kushagra, Afzal Feroze, Giurgiutiu Dan-Victor, Rahimi Scott Y, Shah Manan, Switzer Jeffrey A, Vale Fernando L, Garcia Klepper Alfredo
Departments of Neurology and.
Neurosurgery, Augusta University, Augusta, Georgia.
J Neurosurg Case Lessons. 2021 Jun 7;1(23):CASE2080. doi: 10.3171/CASE2080.
Acute promyelocytic leukemia (APL) has long been associated with coagulation disorders. The proposed mechanism is a combination of fibrinolysis, proteolysis, platelet dysfunction, thrombocytopenia, and possibly disseminated intravascular coagulation. Hemorrhagic complications are prominent.
In this case, a 25-year-old female with newly diagnosed APL developed extensive cerebral venous thrombosis (CVT) and was initiated on a protocol with idarubicin and all- retinoic acid. The general recommendation for treating CVT is anticoagulation to stabilize the existing thrombus and prevent propagation. The patient was initiated on a heparin drip, but her clinical course was complicated by subdural hemorrhage (SDH) and epidural hemorrhage in the setting of thrombocytopenia. Anticoagulation was held, and her CVT propagated on follow-up imaging. To restart anticoagulation for CVT with a limited risk of SDH, the authors pursued middle meningeal artery (MMA) embolization. The patient was transitioned to apixaban and discharged to home.
MMA embolization enables safe anticoagulation in patients with concomitant CVT and SDH. The authors report the complex clinical course and effective management of this rare clinical scenario.
急性早幼粒细胞白血病(APL)长期以来一直与凝血障碍有关。提出的机制是纤溶、蛋白水解、血小板功能障碍、血小板减少症以及可能的弥散性血管内凝血的综合作用。出血并发症很突出。
在本病例中,一名新诊断为APL的25岁女性发生了广泛的脑静脉血栓形成(CVT),并开始接受伊达比星和全反式维甲酸治疗方案。治疗CVT的一般建议是进行抗凝以稳定现有血栓并防止其蔓延。该患者开始静脉滴注肝素,但在血小板减少的情况下其临床病程因硬膜下出血(SDH)和硬膜外出血而变得复杂。抗凝治疗暂停,其CVT在后续影像学检查中蔓延。为了在SDH风险有限的情况下重新开始对CVT进行抗凝治疗,作者采用了脑膜中动脉(MMA)栓塞术。该患者改用阿哌沙班并出院回家。
MMA栓塞术可使合并CVT和SDH的患者安全地进行抗凝治疗。作者报告了这一罕见临床情况的复杂临床病程及有效管理。